News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
685,435 Results
Type
Article (39040)
Company Profile (279)
Press Release (646116)
Section
Business (203861)
Career Advice (1988)
Deals (35362)
Drug Delivery (85)
Drug Development (80799)
Employer Resources (168)
FDA (16086)
Job Trends (14802)
News (344536)
Policy (32435)
Tag
Academia (2530)
Alliances (49077)
Alzheimer's disease (1228)
Approvals (16018)
Artificial intelligence (128)
Bankruptcy (352)
Best Places to Work (11533)
Biotechnology (200)
Breast cancer (119)
Cancer (1069)
Cardiovascular disease (97)
Career advice (1658)
Cell therapy (230)
Clinical research (64225)
Collaboration (379)
Compensation (195)
COVID-19 (2530)
C-suite (94)
Data (1109)
Diabetes (152)
Diagnostics (6135)
Earnings (84812)
Employer resources (146)
Events (109436)
Executive appointments (303)
FDA (16614)
Funding (345)
Gene therapy (176)
GLP-1 (574)
Government (4323)
Healthcare (18668)
Infectious disease (2614)
Inflammatory bowel disease (106)
Interviews (308)
IPO (16295)
Job creations (3623)
Job search strategy (1416)
Layoffs (412)
Legal (7853)
Lung cancer (170)
Manufacturing (174)
Medical device (13172)
Medtech (13177)
Mergers & acquisitions (19137)
Metabolic disorders (398)
Neuroscience (1501)
NextGen Class of 2024 (6499)
Non-profit (4464)
Northern California (1467)
Obesity (228)
Opinion (179)
Patents (101)
People (56253)
Phase I (19942)
Phase II (28288)
Phase III (21094)
Pipeline (453)
Postmarket research (2553)
Preclinical (8487)
Radiopharmaceuticals (235)
Rare diseases (217)
Real estate (5889)
Regulatory (21514)
Research institute (2308)
Resumes & cover letters (349)
Southern California (1293)
Startups (3561)
United States (13342)
Vaccines (548)
Weight loss (166)
Date
Today (204)
Last 7 days (866)
Last 30 days (3778)
Last 365 days (35606)
2024 (32541)
2023 (40075)
2022 (51173)
2021 (55712)
2020 (54087)
2019 (46541)
2018 (35019)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (713)
Arizona (192)
Asia (37109)
Australia (6057)
California (3296)
Canada (1276)
China (245)
Colorado (143)
Connecticut (150)
Europe (79481)
Florida (453)
Georgia (116)
Illinois (338)
Indiana (194)
Kansas (96)
Maryland (573)
Massachusetts (2580)
Michigan (153)
Minnesota (270)
New Jersey (947)
New York (948)
North Carolina (696)
Northern California (1467)
Ohio (138)
Pennsylvania (838)
South America (1091)
Southern California (1293)
Texas (456)
Utah (89)
Washington State (356)
685,435 Results for "ambiopharm inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
AmbioPharm Appoints Industry Veteran Brian Gregg as CEO
AmbioPharm, a worldwide leader in peptide active pharmaceutical ingredient contract development and manufacturing organization services, announced the appointment of industry veteran Brian Gregg as Chief Executive Officer.
October 2, 2023
·
2 min read
Business
AmbioPharm Provides an Update on South Carolina Headquarters Expansion
AmbioPharm, a worldwide leader in peptide API CDMO services, continues growth to meet capacity demands for late phase and commercial peptide production while increasing our sustainability efforts.
May 17, 2023
·
2 min read
BioMidwest
AmbioPharm to Host a Sustainable Peptide Manufacturing Workshop at Biologics 2023
AmbioPharm, a worldwide leader in peptide API CDMO services, to host a workshop on sustainable peptide manufacturing at Biologics 2023 taking place in London, UK on March 29, 2023.
March 22, 2023
·
2 min read
Business
Ariceum Therapeutics and AmbioPharm Enter Strategic Manufacturing and Supply Partnership
Ariceum Therapeutics (Ariceum) and AmbioPharm, a global peptide contract development and manufacturing organization, today announce that they have entered into a strategic partnership for the manufacture and supply of peptide conjugates to be used by Ariceum in future clinical studies.
October 27, 2022
·
3 min read
Drug Development
AmbioPharm Supports ONL Therapeutics with Peptide Manufacturing to Prepare for IND Application for Phase 2 Study
AmbioPharm, a global peptide CDMO, is a key partner in peptide manufacturing and development for ONL Therapeutics (ONL), a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal disease.
July 12, 2022
·
3 min read
Business
CEM Corporation & AmbioPharm Form U.S. Partnership for GMP Peptide Production
CEM Corporation and AmbioPharm, Inc. are excited to announce the formation of a partnership for production of GMP peptides for the global market.
September 14, 2021
·
4 min read
Press Releases
ABS Bio, Inc. announces strategic investment by 3 Boomerang Capital
◆Investment to support services growth. ◆Industry veterans join board of directors, including John Chickosky as Executive Chairman, and Greg Swanberg and Martin LeBlanc as Directors.
November 14, 2024
·
1 min read
Drug Development
OKYO Pharma Plans Q4 2022 IND Filing of OK-101 to treat Dry Eye Disease with Subsequent Phase 2 Initiation Alongside Peptide Manufacturing Partner, AmbioPharm
OKYO Pharma Limited, a biotechnology company focused on the discovery and development of novel molecules to treat inflammatory dry eye diseases and ocular pain, plans aQ4 2022 IND filingfor OK-101 to treat dry eye disease, with AmbioPharm playing a key role in peptide manufacturing and development.
August 30, 2022
·
5 min read
BioMidwest
AmbioPharm Inc. Announces New Shanghai Campus Opening and European Executive Team Members
AmbioPharm Inc., a worldwide leader in peptide API CDMO services, has recently opened its new Shanghai campus.
January 7, 2021
·
1 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
1 of 68,544
Next
